Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Photo: Wollertz/Shutterstock.com

Purdue Pharma has sought to delay a trial that is set to begin May 28 in Oklahoma, citing a “belated tidal wave of documents,” but the move comes amid reports that the opioid manufacturer could soon file for Chapter 11 bankruptcy.

This premium content is locked for
Litigation Daily subscribers only.

*May exclude premium content
Already have an account?
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to groupsales@alm.com to learn more.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.